Biotechnology Regulatory Authority Of India B

Rediff.com » News » Biotechnology Regulatory Authority Of India B

News for Biotechnology Regulatory Authority Of India B

Business

Educating India, in a B-Grade American style

In a blog posted on March 16, 2010, Devinder Sharma,a New Delhi-based food and trade policy analyst, columnist and activist argues why allowing foreign universities to set up campuses in India is......

Finance Minister P Chidambaram's speech

Mr. Speaker, SirIt is my privilege to present the Budget for 2007-08.I. A MID-TERM REPORT CARD ON THE ECONOMY2. In November 2006, the UPA Government crossed the midpoint of its term of office. A......

Chidambaram's Budget speech

Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......

Biotech sector eyes $4,500 mn by '10

Fuelled by growing markets and a liberalised economy, the Indian biotech industry is set to witness an exponential growth with an estimated turnover of $4,500 million by 2010. New policies......

Web results for Biotechnology Regulatory Authority Of India B

Forecast 2015

As 2014 draws to a close, Express Pharma presents some hopes and predictions from thought leaders as they gaze into their crystal balls We... ...

http://www.financialexpress.com/article/pharma/cover-story/forecast-2015/27085/

Infusion Pumps Market Forecast 2014-2024

/PRNewswire/ -- Prospects for Leading Companies Report Details Infusion pumps - new study showing you trends, R&D progress, and... ...

http://in.advfn.com/p.php?pid=nmona&article=64742166

Transfusing Life Through Automation

Automation is certainly the future trend that will completely take over the manual segment and dominate the whole market, with the high price... ...

http://ehealth.eletsonline.com/2014/12/transfusing-life-automation/

Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting

- San Francisco, United States Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) has announced four-year... ...

http://www.andhranews.net/Intl/2014/Seattle-Genetics-Takeda-Announce-Four-Year-Survival-3556.htm

BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and

VANCOUVER, British Columbia, Dec. 3, 2014 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp (TSX-V:BCT) ("BriaCell", the "Company", or "BCT") is... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=52606

See All

Rediff News

Biotechnology Regulatory Authority Of India B

News for Biotechnology Regulatory Authority Of India B

Educating India, in a B-Grade American style

Finance Minister P Chidambaram's speech

Chidambaram's Budget speech

Biotech sector eyes $4,500 mn by '10

Related Tags

Top Coverage News

Coming to India and making

Commonwealth Games - 2014

The defence coverage of Rediff.com

The ISIS war in Iraq

India's tour of England 2014